Results 121 to 130 of about 59,358 (257)
IL-21 expression during sublingual immunotherapy for allergic rhinitis. [PDF]
Wang C, Qin X, Jiang L, Zhang T.
europepmc +1 more source
High‐dose birch‐extract nasal challenge induced synchronous peaks at 4 weeks in serum specific IgE (sIgE) and basophil sensitivity. Mast cell sensitivity via tSPT and sIgG1 and sIgG4 responses peaked later, at 6–8 weeks. Preseasonal allergen exposure attenuated seasonal sIgE increase and prevented further rise in tSPT sensitivity.
N. J. Campion +18 more
wiley +1 more source
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis. [PDF]
Zhang Y +37 more
europepmc +1 more source
MAT is dependent on the presence of allergen‐specific IgE and can provide false‐negative results in allergic patients with low allergen‐specific IgE levels. MAT and BAT are moderately correlated. MAT can be used as a surrogate of BAT, when fresh blood is not available or in the case of patients with non‐releaser basophils.
Vikki Houghton +6 more
wiley +1 more source
The relationship between allergic rhinitis and sleep disorders and mental health. [PDF]
Feng X, Gu Z, Wang Y.
europepmc +1 more source
Family Size and Food Allergy in Early Childhood: The Japan Environment and Children's Study
Allergy, EarlyView.
Takayasu Nomura +27 more
wiley +1 more source
ABSTRACT Background To achieve adequate symptom control, patients with allergic rhinitis (AR) often need to increase their medication dose or add other treatments (co‐medication). We aimed to perform a systematic review to compare the efficacy and safety of AR medications for increased dose versus co‐medication.
Bernardo Sousa‐Pinto +44 more
wiley +1 more source
Androgenetic alopecia risk in allergic rhinitis: A cohort study of immune and antihistamine effects. [PDF]
Zhang HW +5 more
europepmc +1 more source

